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Does size matter?
 
For 40 years, the debate has raged.
Do mammalian cells monitor cell size
when deciding whether to divide?
More recent models suggest an indi-
rect solution, but the ﬁeld is far from
reaching a ﬁnal verdict.
 
The cell cycle has provided us with some 
of the most spectacular examples of 
evolutionary conservation, with several 
 
key enzymes and entire regulatory 
cassettes being interchangeable between 
yeast and mammals. But when it comes 
to the control of growth and division in 
G1, the story is a little different.
 
G1 is the critical phase during which 
both budding yeast and mammalian cells 
commit to another cycle. The question is 
whether both cell types take growth, as 
measured by cell size, into account when 
making the decision to divide.
“The classical view in yeast, more or 
less completed by 1980, is that growth 
is just growth, making more mass, and 
then there is a critical checkpoint 
where that is monitored, probably by 
G1 cyclin synthesis,” says Fred Cross 
(Rockefeller University, New York, 
NY). “Those experiments are pretty 
good. In mammalian cells it is less clear 
that this view applies.”
The yeast work showed that whereas 
growth continues during cell-cycle 
delays, the cell cycle halts during growth 
delays (Johnston et al., 1977). That put 
the emphasis on cell size checkpoints. 
But now researchers such as Ian Conlon 
and Martin Raff (University College, 
London, UK) are arguing that mam-
malian cells rely only on a balance of 
progrowth and prodivision extracellular 
signals to make their G1 decisions.
A different story came from Bruce 
Futcher (State University of New York, 
Stony Brook, NY) at the recent FASEB 
conference on Receptors and Signal 
Transduction (Salt Lake City, Utah, 
June 29–July 3). He claimed that yeast 
and mammalian cells might resemble 
each other more than has been thought. 
“In the bits where we understand quite 
well what’s happening, they are very 
similar,” he says. “The bits where peo-
ple imagine they are different are all 
bits where we don’t really understand 
what is happening.”
 
From yeast to mammals
 
Futcher has promoted a model in 
which the yeast G1 cyclin Cln3p 
accumulates at a rate that is determined 
by the volume of cytosol. As the 
cytosol increases in size, more Cln3p 
accumulates but the size of the nucleus 
stays relatively constant, leading to 
a higher concentration of Cln3p in 
the nucleus. This eventually propels 
the cell through the cell cycle decision 
point, which in yeast is called START 
(Hartwell and Unger, 1977).
In his talk, Futcher showed that 
increasing the size of the nucleus by 
10% (by adding a prolific but innocuous 
plasmid) led to an 8% increase in 
critical size. The smallest cells to bud 
in this experiment were almost all 
plasmid-negative.
Similarly detailed models have not 
been forthcoming in mammalian cells. 
But some early experiments did indicate 
that size is important. Anders Zetterberg 
(Karolinska Institute, Stockholm, 
Sweden) found in 1965 that the post-
mitotic mass of 21 populations of mouse 
fibroblasts correlated with the length of 
their G1 period, with smaller cells having 
a longer G1 (Killander and Zetterberg, 
1965) (Fig. 1). As a result, small and large 
cells entered S phase at almost the same 
cell size, which made these mammalian 
cells look a lot like yeast. On the basis of 
these and later experiments, Zetterberg 
says that “there is probably some kind of 
active size control.”
When, in mammalian cells, would 
such a size control operate? Zetterberg’s 
later experiments indicated that the 
mammalian restriction point—the 
transition from mitogen-dependent to 
mitogen-independent growth—is not 
equivalent to yeast START, since it is 
not the point at which growth is assessed. 
Zetterberg found that the period up to 
the restriction point was invariant, 
with the size-dependent variation in 
timing coming during G1 but after the 
restriction point.
Further evidence suggestive of size 
control was reported at the Utah 
conference by Wei-Xing Zong (Uni-
versity of Pennsylvania, Philadelphia, 
PA), who spoke about work performed 
by Marian Harris in Craig Thompson’s 
laboratory. Harris used cells that, 
because they lack two key apoptotic 
proteins, no longer die when starved 
of interleukin 3 (IL-3) for a month. 
When IL-3 was added back to these 
suspended animation cells, they 
started increasing in size almost 
immediately. But they did not enter 
S phase for 10–14 d, by which time 
their cell size was almost equal to that 
of normal cycling G1 cells. Again, this 
looks like size is monitored during the 
cell cycle. The cells may, however, be 
rebuilding certain essential organelles or 
cellular structures during the lag period.
When it comes to the more direct, 
Zetterberg-like experiments, others 
have found either the presence (Yen 
et al., 1975) or absence (Fox and 
Pardee, 1970) of correlation between size 
and G1 duration. “It’s still never been 
settled whether there is a critical size for 
mammalian cells,” says Jim Roberts 
(Fred Hutchinson Cancer Research 
Center, Seattle, WA). “In different 
kinds of cells you get different answers.” 
Most cell types present one or another 
problem for these experiments. Some 
transformed cells may lack certain cell 
cycle controls, and primary cells tend 
to be adherent and thus difficult to 
size accurately. For now, Roberts 
doubts that the phenomenon exists: “I 
would say, go back to the original 
work and prove to me that there is size 
control.”
 
Do mammalian cells monitor 
 
their size? 
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Dispensability and randomness
 
This view is seconded by Robert Brooks 
(King’s College, London, UK). Initially, 
he was concerned that, without a cell 
size checkpoint, any size difference in a 
population might be amplified by 
continued, runaway growth. But, he 
says, “that sort of thing is true only if 
growth is exponential. If that isn’t the 
case, you don’t absolutely have to 
have a size control.”
Exponential growth (not to be 
confused with exponential division) 
means an increase in the rate of mass 
accumulation during the cell cycle. “In 
yeast, growth looks more compellingly 
exponential,” says Brooks. “In mam-
malian cells, this is not the case.” Indeed, 
Brooks found that 3T3 cells that start 
off larger actually grew more slowly than 
their smaller counterparts, suggesting 
that cell size would return to a mean 
without the need for a cell size check-
point (Brooks and Shields, 1985). This 
conflicts, however, with Zetterberg’s 
demonstration that the rate of RNA 
and mass accumulation in mouse 
fibroblasts increases as interphase 
progresses (Zetterberg and Killander, 
1965).
Return to a mean is compatible with 
a G1 transition governed not by size 
but by a random probability event. 
Brooks and colleagues put forward this 
idea to explain the variability in timing 
of S phase onset in 3T3 cells (Shields et 
al., 1978), and Brooks sees a version of 
it in his current experiments, in which 
different nuclei in a single frog extract 
enter S phase at different times (Hola et 
al., 1996). The nature of this nuclear-
localized trigger remains elusive.
 
The extracellular camp
 
Raff sees the concept of a cell size 
checkpoint in mammalian cells as both 
unnecessary, based on the lack of 
exponential growth, and unlikely, 
based on the differing biology between 
yeast and mammalian cells. “I’m pretty 
confident that you don’t need it and 
that the cells that we have looked at 
don’t have it,” he says.
Conlon and Raff have focused on 
the effect of extracellular signals. They 
have found that IGF-1 promotes cell 
growth and cell cycle progression of 
rat Schwann cells, but glial growth 
factor (GGF) promotes only cell cycle 
progression. Increasing GGF leads to 
more rapid division and progressively 
smaller cells, suggesting that the cells 
are not held up by an intracellular G1 
program that measures size (Conlon et 
al., 2001).
“The field has bought the idea of size 
control, hook, line, and sinker, on the 
basis of yeast experiments,” says Raff. 
But yeast cells are limited by the level 
of nutrients in the medium, whereas 
the cells of multicellular animals, 
swimming in a soup of nutrients, have 
their growth limited mainly by extra-
cellular signals. Regulation based on 
these signals would allow cell size to be 
controlled on an organismal rather 
than single cell level. “This is very 
different from yeast cells,” says Raff. 
“A fundamental difference.”
Conlon and Raff point to their recent 
experiments in which Schwann cells 
were shifted between different growth 
conditions. The cells took over a week 
to reach their new characteristic size, 
suggesting a gradual, growth-driven 
process rather than a strict cell size 
checkpoint. By contrast, fission yeast 
cells subject to similar shift experiments 
(Fantes and Nurse, 1977) undergo 
rapid, single cycle changes that support 
the notion of a cell size checkpoint.
 
Measure rate not size
 
There may, however, be a middle 
ground. For starters, some researchers 
believe that both types of cells may be 
responding to levels of intracellular 
nutrients. In yeast, those intracellular 
levels may directly reflect the levels of 
extracellular nutrients, whereas in 
mammalian cells the intracellular levels 
may be determined by transporters 
regulated by Raff’s extracellular signals. 
“As always in evolution,” says Mike 
Tyers (University of Toronto, Canada), 
“it is a question of building on additional 
regulatory layers.”
Then, there is the translation 
argument. Several investigators propose 
that, rather than directly gauging cell 
 
size, cell cycle regulators are especially 
sensitive to translation capacity and 
that translation capacity is thus used 
as a way to communicate growth levels 
to the cell cycle.
The clearest example of this again 
comes from yeast work. Emmett 
Schmidt (Massachusetts General 
Hospital, Charlestown, MA) has 
found that the budding yeast gene 
encoding Cln3p has an upstream open 
reading frame (uORF) that represses 
 
CLN3
 
 expression. The uORF makes 
successful 
 
CLN3
 
 expression (as measured 
by polysomal profiles and not, unfor-
tunately, by Cln3p levels) dependent 
on a high concentration of ribosomes 
(Polymenis and Schmidt, 1997). A 
similar mechanism may operate in 
fission yeast, although in this case the 
cell cycle component with exceptional 
translation sensitivity is Cdc25, a phos-
phatase that controls entry into mitosis 
(Daga and Jiminez, 1999).
This coupling between bulk synthesis 
rate and cell cycle components is similar 
to that proposed by Bruce Edgar (Fred 
Hutchinson Cancer Research Center, 
Seattle, WA) for a beast that is, if not 
mammalian, then at least multicellular. 
For flies, says Edgar, “there is a measure-
ment mechanism, but I don’t think it’s 
measuring size. My opinion, and it’s 
really an opinion, is that protein synthesis 
rates can affect cell division rates, and in 
particular rates of G1/S progress. A cell 
with a higher protein synthesis rate 
Figure 1. Cells that start off G1 larger gain 
less mass during G1. Correlations such as this 
led Zetterberg to propose that size control 
applies in mammalian cells (see text).
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would have a higher rate of initiating 
G1/S transitions. That would indirectly 
give you a cell size measuring mechanism.”
To support such a model, Edgar has 
introduced growth promoters such as 
Myc, Ras, and components of the 
insulin pathway. Myc, in particular, 
increases both ribosome biogenesis and 
translation rates. Levels of a critical G1 
cyclin called cyclin E are also increased. 
This may be mediated by an increase 
in protein stability, but an alternative 
explanation is that the increased 
translation rates combat the constitutive 
instability of the cyclin E protein. 
Thus, this increase in translation 
could provide the critical boost that 
links growth to cell cycle progression.
These models rely on cell cycle 
transcripts being second class citizens 
that are not translated until a critical 
level of ribosomes is available. Consistent 
with this idea, several experiments 
suggest that mammalian cells take care 
of growth before tackling division. S6 
kinase, for example, directs preferential 
translation by sending ribosomes to 
the oligopyrimidine tracts at the 5
 
 
 
 end 
of ribosomal protein mRNAs. This 
system first churns out more raw 
materials for ribosomes, and only when 
those excess ribosomes have been 
created will the cell have the capacity to 
move onto other mRNAs, such as those 
encoding cell cycle regulators. George 
Thomas (Friedrich Miescher Institute, 
Basel, Switzerland) uses this argument to 
explain why his S6 kinase mutant flies 
have smaller cells (Montagne et al., 1999), 
since they have lost this control and thus 
make excessive cell cycle regulators that 
drive division over growth.
Thomas has further evidence for 
growth before division in mammalian 
cells. In mouse liver cells, he has pre-
vented increases in ribosome numbers 
with a conditional knockout of the S6 
ribosomal protein and then subjected 
those cells to tests of either growth or 
division. The cells were able to use their 
limited number of ribosomes to grow in 
size after starvation and refeeding but 
were unable to divide to replace liver 
mass that had been removed by surgery 
(Volarevic et al., 2000). Thus, once 
again, growth can be turned on more 
easily than cell division.
 
Then, there is the TOR connection. 
The target of rapamycin (TOR) is the 
focal point for a web of pathways that 
regulate growth in response to nutrient 
availability. But rapamycin, a TOR 
inhibitor that shuts down only a small 
subset of translation, halts not only 
growth but also entry into S phase. This 
suggests that TOR uses its assessment of 
nutrients and growth to regulate both 
growth and division. “I think rapamycin 
is the best evidence that there is a link 
here,” says Nahum Sonenberg (McGill 
University, Montreal, Canada).
 
Growth anticipation
 
One of the peculiarities of the growth-
and-division field is the distribution of 
the literature. After some careful experi-
ments starting in the 1960s, there has 
been a long silence. A major reason 
for the hiatus was that attention was 
focused primarily on the cell cycle, 
but in yeast there was another factor.
“There has been a two decade inter-
ruption, really for the want of cloning 
whi mutants,” says Tyers. It is easy 
enough to isolate yeast mutants that 
are small (wee in fission yeast, for their 
isolation in Edinburgh; whi in budding 
yeast, for a bet over a bottle of Irish 
whiskey), but there is no selection to 
clone the relevant genes. Recently 
Tyers got around this problem by 
testing the cell sizes of the complete 
set of 
 
 
 
6,000 budding yeast deletion 
strains (Jorgensen et al., 2002). This 
unbiased search gave him a clear answer. 
“Basically yeast are bags of ribosomes that 
must coordinate with the cell cycle,” he 
says. “Our view of START has changed a 
lot over the past year.”
The ribosome-centric view arose 
because the clearest size mutants had 
defects in ribosome synthesis. But they 
were not suffering from a general 
incapacitation—rather, they were 
uncoupled for growth and division, 
with their growth capability far more 
compromised than their division 
capability.
So far, this story sounds consistent 
with the S6 experiments, and Tyers 
agrees that “it’s a very simple idea to 
view the cell cycle commitment step 
as a passive output of translation.” But 
Tyers believes in a more active and 
direct mechanism in which ribosome 
biogenesis is monitored. Some of his 
deletions are in genes that function 
very early on in ribosome biogenesis. 
“The fact that these factors are clearly 
not functioning as part of the ribosome 
but as part of an assembly pathway 
leads to the argument that it is an 
anticipatory change,” he says.
So what does this pathway tell the 
cell cycle? The Whi phenotype of
Tyers’ mutants gives a surprising 
answer—it suggests that the normal 
versions of these factors promote both 
ribosome biogenesis (more growth) and 
cell cycle inhibition (less division, as 
mutation causes more division leading 
to the smaller size).
This reverse coupling of growth and 
division seems counterintuitive for 
homeostatic growth, but it might be 
perfect for adjusting to different 
environments. It fits, for example, with 
the simple observation that budding 
yeast cells are larger on rich media. And 
Futcher has found that G1 cyclins are 
less abundant when cells are grown on 
poor carbon sources, which is when 
they go through START at a smaller 
size. This phenotype (less cyclins, 
lower critical size) could be seen as 
contradicting the models in which 
cyclins measure size and act as the 
threshold for division, but Futcher 
prefers to see it as an adjustment 
mechanism. “It would be an awfully 
poor and stupid cell,” he says, “if it 
couldn’t adjust for the things in its 
environment.”
Once the threshold is adjusted and 
nutrient supply is stable, the relative 
concentration of a cyclin may still 
coordinate cell size with the G1 to S 
transition. But the resetting during 
changing growth conditions may rely on 
Tyers’ progrowth, antidivision pathway.
 
Pathway profusion
 
Futcher’s original point was that 
both yeast-like and mammalian-like 
pathways may exist in both cell types. 
Mammalian cells, like yeast, may 
monitor growth to influence cell divi-
sion. And yeast cells, like mammalian 
cells, may use extracellular factors (such 
as glucose) to send signals directly to 
the cell-cycle machinery. Evidence for  
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the latter pathway comes, for example, 
from the glucose-dependent 
 
CLN3
 
 
transcription factor Azf1p (Newcomb 
et al., 2002).
The relative importance of these path-
ways may differ in different organisms 
and cell types, and clearly it will take 
many more years to decipher which 
components are defining the critical set 
point for a given cell type. Cross feels 
that older models—in which growth 
and division were cleanly separated— 
may be supplanted by messier but 
more realistic wiring diagrams. “In the 
end,” he says with a laugh, “there will 
no doubt be arrows pointing all over 
the place in some incomprehensible 
manner.”
 
William A. Wells
wellsw@rockefeller.edu
 
References
 
Brooks, R.F., and R. Shields. 1985. Cell growth, cell
division and cell size homeostasis in Swiss 3T3
 
cells. 
 
Exp. Cell Res.
 
 156:1–6.
Conlon, I.J., G.D. Dunn, A.W. Mudge, and M.C.
Raff. 2001. Extracellular control of cell size. 
 
Nat.
Cell Biol.
 
 3:918–921.
Daga, R.R., and J. Jiminez. 1999. Translational con-
trol of the Cdc25 cell cycle phosphatase: a molecu-
lar mechanism coupling mitosis to cell growth. 
 
J.
Cell Sci.
 
 112:3137–3146.
Fantes, P., and P. Nurse. 1977. Control of cell size at
division in fission yeast by a growth-modulated size
control over nuclear division. 
 
Exp. Cell Res.
 
 107:
377–386.
Fox, T.O., and A.B. Pardee. 1970. Animal cells: non-
correlation of length of G1 phase with size after mi-
tosis. 
 
Science.
 
 167:80–82.
Hartwell, L.H., and M.W. Unger. 1977. Unequal di-
vision in 
 
Saccharomyces cerevisiae
 
 and its implica-
tions for the control of cell division. 
 
J. Cell Biol.
 
 75:
422–435.
Hola, M., M. Howard, F.N. Nawaz, S. Castleden,
and R.F. Brooks. 1996. Individual nuclei differ in
their sensitivity to the cytoplasmic inducers of
DNA synthesis: implications for the origin of cell
cycle variability. 
 
Exp. Cell Res.
 
 229:350–359.
Johnston, G.C., J.R. Pringle, and L.H. Hartwell.
1977. Coordination of growth with cell division in
the yeast 
 
Saccharomyces cerevisiae.
 
 
 
Exp. Cell Res.
 
105:79–98.
Jorgensen, P., J.L. Nishikawa, B.-J. Breitkreutz, and
M. Tyers. 2002. Systematic identification of path-
ways that couple cell growth and division in yeast.
 
Science.
 
 297:395–400.
Killander, D., and A. Zetterberg. 1965. A quantitative
cytochemical investigation of the relationship be-
tween cell mass and initiation of DNA synthesis in
mouse fibroblasts in vitro. 
 
Exp. Cell Res.
 
 40:12–20.
Montagne, J., M.J. Stewart, H. Stocker, E. Hafen, S.C.
Kozma, and G. Thomas. 1999. 
 
Drosophila
 
 S6 ki-
nase: a regulator of cell size. 
 
Science.
 
 285:2126–2129.
Newcomb, L.L., D.D. Hall, and W. Heideman.
2002. AZF1 is a glucose-dependent positive regula-
tor of 
 
CLN
 
3 transcription in 
 
Saccharomyces cerevi-
siae.
 
 
 
Mol. Cell. Biol.
 
 22:1607–1614.
Polymenis, M., and E.V. Schmidt. 1997. Coupling of
cell division to cell growth by translational control
of the G1 cyclin 
 
CLN
 
3 in yeast. 
 
Genes Dev.
 
 11:
2522–2531.
Shields, R., R.F. Brooks, P.N. Riddle, D.F. Capellaro,
and D. Delia. 1978. Cell size, cell cycle and transi-
tion probability in mouse fibroblasts. 
 
Cell.
 
 15:469–
474.
Volarevic, S., M.J. Stewart, B. Ledermann, F. Zilber-
man, L. Terracciano, E. Montini, M. Grompe,
S.C. Kozma, and G. Thomas. 2000. Proliferation,
but not growth, blocked by conditional deletion of
40
 
S
 
 ribosomal protein S6. 
 
Science.
 
 288:2045–2047.
Yen, A., J. Fried, T. Kitahara, A. Strife, and B.D.
Clarkson. 1975. The kinetic significance of cell
size. 
 
Exp. Cell Res.
 
 95:295–302.
Zetterberg, A., and D. Killander. 1965. Quantitative
cytochemical studies on interphase growth. 
 
Exp.
Cell Res.
 
 39:22–32.